Company Active LTD

Company profile

Signifier Medical Technologies Limited

Signifier Medical Technologies

Driving Innovation in the Sleep MarketSignifier Medical Technologies (SMT) is a medical technology company focused on the development and commercialisation of innovative and non-invasive solutions for patients with sleep-disordered breathing conditions and snoring. Pioneers in challenging the wisdom of conventional sleep apnoea and snoring treatments, we've created the first daytime therapy that tackles the root cause of sleep-disordered breathing by physiologically retraining the airway against collapse.

CRN
09455560
Founded
2015
Age
11

Overview

Legal name
SIGNIFIER MEDICAL TECHNOLOGIES LIMITED
Region
South East England
Registered address
22A BANK STREET
ASHFORD
ENGLAND
TN23 1BE
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

19 events
14 Jan
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Dec
2026

Accounts due

Accounts Due

Next accounts due date

19 Jun
2026

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzUyNzM5NzA1N2FkaXF6a2N4

Published 19 Jun 2026 18:07

31 Dec
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Mar
2025

Accounts filed

Accounts

Last accounts made up date

19 Sep
2024

Change Person Director Company With Change Date

Officers

CH01 | Transaction MzQzNjU1OTI4MWFkaXF6a2N4

Published 19 Sep 2024 18:15

19 Sep
2024

Change Person Director Company With Change Date

Officers

CH01 | Transaction MzQzNjU1OTI1M2FkaXF6a2N4

Published 19 Sep 2024 18:13

19 Sep
2024

Change Person Director Company With Change Date

Officers

CH01 | Transaction MzQzNjU1OTE5NmFkaXF6a2N4

Published 19 Sep 2024 18:11

19 Sep
2024

Change Person Director Company With Change Date

Officers

CH01 | Transaction MzQzNjU1OTE4MGFkaXF6a2N4

Published 19 Sep 2024 18:10

19 Sep
2024

Change Person Director Company With Change Date

Officers

CH01 | Transaction MzQzNjU1OTE1N2FkaXF6a2N4

Published 19 Sep 2024 18:09

19 Sep
2024

Change Person Director Company With Change Date

Officers

CH01 | Transaction MzQzNjU1OTE1NmFkaXF6a2N4

Published 19 Sep 2024 18:09

19 Sep
2024

Change Person Director Company With Change Date

Officers

CH01 | Transaction MzQzNjU1OTEyOGFkaXF6a2N4

Published 19 Sep 2024 18:07

19 Sep
2024

Change Person Director Company With Change Date

Officers

CH01 | Transaction MzQzNjU1OTA3NGFkaXF6a2N4

Published 19 Sep 2024 18:06

19 Sep
2024

Confirmation Statement With Updates

Confirmation-statement

CS01 | Transaction MzQzNjUyOTgwMWFkaXF6a2N4

Published 19 Sep 2024 12:29

17 Sep
2024

Change Registered Office Address Company With Date Old Address New Address

Address

AD01 | Transaction MzQzNjIzNjM2OGFkaXF6a2N4

Published 17 Sep 2024 18:59

17 Sep
2024

Appoint Person Director Company With Name Date

Officers

AP01 | Transaction MzQzNjIzNjMwMGFkaXF6a2N4

Published 17 Sep 2024 18:56

17 Sep
2024

Capital Allotment Shares

Capital

SH01 | Transaction MzQzNjIzNjAxN2FkaXF6a2N4

Published 17 Sep 2024 18:44

14 Sep
2024

Change Registered Office Address Company With Date Old Address New Address

Address

AD01 | Transaction MzQzNTg5OTA4MGFkaXF6a2N4

Published 14 Sep 2024 09:09

24 Feb
2015

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2017
Funded years
2017, 2019
Age at first award
2 years

Projects

2019 Collaborative R&D Lead participant

Connected and intelligent device for personalised diagnostic, treatment and management of sleep breathing disorders. SnooZeal-Connect

1 May 2019 to 31 Mar 2021

Awarded
£261,547
Total cost £373,638

Obstructive Sleep Apnoea is a condition where the muscles and soft tissues in the throat relax and collapse sufficiently to cause a total blockage of the airway for 10 seconds or more during sleep. OSA is a potentially deadly condition in extreme cases but for moderate OSA patients, fatigue from regularly disturbed sleep can impact heavily on quality of l...

2017 Collaborative R&D Lead participant

A conductive silicone mouthpiece to stimulate the tongue muscle to address root cause of Sleep Apnoea

1 Jul 2017 to 30 Jun 2019

Awarded
£393,303
Total cost £561,862

Obstructive Sleep Apnoea (OSA) is a sleep related respiratory condition, leading to repeated temporary cessations of breathing because of a narrowing or closure of the upper airway during sleep. Core symptoms of OSA include excessive daytime sleepiness and snoring. OSA can affect anyone, but is more common in some people, e.g. those who are male, middle a...

Product types

Collaborative R&D